Evidence map›Paper›PMID 34071149›Full record

ArticleCells2021

Immunosuppression as a Hallmark of Critical COVID-19: Prospective Study.

Elżbieta Kalicińska, Donata Szymczak, Aleksander Zińczuk, Barbara Adamik, Jakub Smiechowicz, Tomasz Skalec, Danuta Nowicka-Suszko, Monika Biernat, Aleksandra Bogucka-Fedorczuk, Justyna Rybka and 4 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.4field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Atypical herpetic ulcerations in COVID-19 positive patients: A report of three cases.Oral surgery, oral medicine, oral pathology and oral radiology · 2023
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Observational
  20. COVID-19 and Psychotic Symptoms: the View from Psychiatric Immunology.Current behavioral neuroscience reports · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Elżbieta KalicińskaDepartment and Clinic of Hematology, Blood Neoplasms, and Bone Marrow Transplantation, Wroclaw Medical University, 50-367 Wroclaw, Poland.
Donata SzymczakDepartment and Clinic of Hematology, Blood Neoplasms, and Bone Marrow Transplantation, Wroclaw Medical University, 50-367 Wroclaw, Poland.
Aleksander ZińczukDepartment of Infectious Diseases and Hepatology, Wroclaw Medical University, 51-149 Wroclaw, Poland.ORCID 0000-0003-4725-123X
Barbara AdamikDepartment of Anesthesiology and Intensive Therapy, Wroclaw Medical University, 50-556 Wroclaw, Poland.ORCID 0000-0002-0541-841X
Jakub SmiechowiczDepartment of Anesthesiology and Intensive Therapy, Wroclaw Medical University, 50-556 Wroclaw, Poland.ORCID 0000-0002-2649-0541
Tomasz SkalecDepartment of Anesthesiology and Intensive Therapy, Wroclaw Medical University, 50-556 Wroclaw, Poland.
Danuta Nowicka-SuszkoDepartment of Dermatology and Venereology and Allergology, Wroclaw Medical University, 50-368 Wroclaw, Poland.
Monika BiernatDepartment and Clinic of Hematology, Blood Neoplasms, and Bone Marrow Transplantation, Wroclaw Medical University, 50-367 Wroclaw, Poland.
Aleksandra Bogucka-FedorczukDepartment and Clinic of Hematology, Blood Neoplasms, and Bone Marrow Transplantation, Wroclaw Medical University, 50-367 Wroclaw, Poland.
Justyna RybkaDepartment and Clinic of Hematology, Blood Neoplasms, and Bone Marrow Transplantation, Wroclaw Medical University, 50-367 Wroclaw, Poland.
Adrian MartuszewskiStudents Scientific Association, Department and Clinic of Hematology, Blood Neoplasms, and Bone Marrow Transplantation, Wroclaw Medical University, 50-367 Wroclaw, Poland.ORCID 0000-0002-3620-6380
Waldemar GozdzikDepartment of Anesthesiology and Intensive Therapy, Wroclaw Medical University, 50-556 Wroclaw, Poland.ORCID 0000-0001-8668-1641
Krzysztof SimonDepartment of Infectious Diseases and Hepatology, Wroclaw Medical University, 51-149 Wroclaw, Poland.ORCID 0000-0002-8040-0412
Tomasz WróbelDepartment and Clinic of Hematology, Blood Neoplasms, and Bone Marrow Transplantation, Wroclaw Medical University, 50-367 Wroclaw, Poland.ORCID 0000-0002-6612-3535
Wroclaw Medical University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The dysregulation of both the innate and adaptive responses to SARS-CoV-2 have an impact on the course of COVID-19, and play a role in the clinical outcome of the disease. Here, we performed a comprehensive analysis of peripheral blood lymphocyte subpopulations in 82 patients with COVID-19, including 31 patients with a critical course of the disease. In COVID-19 patients who required hospitalization we analyzed T cell subsets, including Treg cells, as well as TCRα/β and γ/δ, NK cells, and B cells, during the first two weeks after admission to hospital due to the SARS-CoV-2 infection, with marked reductions in leukocytes subpopulations, especially in critically ill COVID-19 patients. We showed decreased levels of Th, Ts cells, Treg cells (both naïve and induced), TCRα/β and γ/δ cells, as well as CD16+CD56+NK cells in ICU compared to non-ICU COVID-19 patients. We observed impaired function of T and NK cells in critically ill COVID-19 patients with extremely low levels of secreted cytokines. We found that the IL-2/INFγ ratio was the strongest indicator of a critical course of COVID-19, and was associated with fatal outcomes. Our findings showed markedly impaired innate and adaptive responses in critically ill COVID-19 patients, and suggest that the immunosuppressive state in the case of a critical course of SARS-CoV-2 infection might reflect subsequent clinical deterioration and predict a fatal outcome.

Indexed as

Immune ToleranceSeverity of Illness IndexAdaptive ImmunityAgedClinical DeteriorationCOVID-19Critical IllnessFemaleHospitalizationHospital MortalityHumansImmunity, InnateLeukocyte CountLymphocyte SubsetsMaleMiddle AgedCOVID-19IL-2IL-2/INFγ ratioimmunosuppressionINFγlymphocyte subsetsNK cellsregulatory T cellsT cellsTCRα/βTCR γ/δ cellsTNFα

Identifiers

PMID34071149
PMCPMC8224622
OpenAlexW3165874639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.